School of Medicine
Showing 1,101-1,150 of 1,239 Results
-
George F Tidmarsh
Adjunct Professor, Pediatrics - Neonatology
Bio Dr. Tidmarsh received M.D. and Ph.D. from Stanford University, where he also completed fellowship training in Pediatric Oncology and Neonatology and is currently Adjunct Faculty of Pediatrics and Neonatology. He served as clinical faculty at Stanford for a number of years after fellowship prior to devoting his full time to clinical research and development in order to bring new treatments through the FDA approval process. Dr. Tidmarsh was President, Chief Executive Officer, Secretary and a Director of La Jolla Pharmaceutical Company from January 2012 until November 2019. While at La Jolla, Dr. Tidmarsh helped discover the use of angiotensin II for the treatment of shock and led all aspects of the development including approval by the US FDA and the EMA for the treatment of patients suffering from distributive shock. He also led the development of artesunate for the treatment of severe malaria, now pending action for potential approval at the FDA. Dr. Tidmarsh has over 30 years of experience in biotechnology, including the successful clinical development of three FDA-approved drugs. He previously served as the Chief Executive Officer of Horizon Pharma, Inc., a company he founded in 2005. While at Horizon, he led all aspects of development of Duexis, which was approved by the FDA for the treatment of rheumatoid arthritis. He also founded Threshold Pharmaceuticals, Inc. and held senior positions at Coulter Pharmaceutical, Inc. (acquired by GlaxoSmithKline) and SEQUUS Pharmaceuticals, Inc. (acquired by Johnson & Johnson). While at Coulter and SEQUUS, Dr. Tidmarsh led the clinical development of BEXXAR and Doxil, respectively, two FDA-approved anti-cancer agents.
At Stanford, Dr. Tidmarsh is devoted to teaching clinical research and development to residents, fellows and junior faculty. In addition, he is working to help improve the quality of medical care through various efforts which include serving on the board of Lucile Packard Foundation for Children's Health. -
Seda Tierney
Associate Professor of Pediatrics (Cardiology) at the Lucile Salter Packard Children's Hospital
Current Research and Scholarly Interests Assessment of vascular health s in children by non-invasive modalities
Echocardiography and outcomes in congenital heart disease -
Sara L. (Sally) Tobin
Sr Research Scholar, Pediatrics - Center for Biomedical Ethics
Current Research and Scholarly Interests Tobin is a Senior Research Scholar at the Stanford Center for Biomedical Ethics. She obtained her Ph.D. in Developmental Biology from the University of Washington and did postdoctoral research in Genetics at the University of California, Berkeley and in Biochemistry at the University of California, San Francisco. She became a faculty member at the University of Oklahoma College of Medicine in 1983 and moved to Stanford University in 1996. Her research contributions have been published in prestigious journals such as Cell, Nature, Genes & Development, Neuron, and Journal of Cell Biology.
Projects
With her collaborator, graphic designer Ann Boughton, Tobin has completed the production of three educational multimedia CD-ROM discs about the genetic revolution in medical care sparked by the rapid advances in our knowledge about the human genome. An on-line version derived and updated from these CDs is pending release through Twisted Ladder Media, and is entitled: "The New Genetics: Medicine and the Human Genome. Molecular Concepts, Applications, and Ramifications." In addition, Tobin and Boughton have collaborated on educational websites on inherited risk of breast cancer and on hereditary colorectal cancer with the Stanford Cancer Genetics Clinic.
Tobin's current major research interests include an educational project funded by the National Science Foundation to create and evaluate innovative modules for undergraduates entitled, "The New Genetics: Electronic Tools for Educational Innovation." The modules are presented in on-line form as an electronic course and are accompanied by workbook exercises and problem sets. The content includes principles of genetics, molecular genetic technologies, applications in medicine, environmental biology, agriculture, and society, as well as implications. In addition, she is collaborating on two projects that are exploring the ramifications of using genetic information about addiction risk in the judicial system.
Tobin is a member of the Benchside Consultation Team for the Center for the Integration of Research on Genetics and Ethics, and she evaluates clinical protocols for ethical issues for the Clinical Translational Research Program. -
Sarina Tom
Education Operations Manager, Pediatrics
Current Role at Stanford Education Operations Manager
Office of Pediatric Education
Stanford Department of Pediatrics -
Michael Tracy
Clinical Assistant Professor, Pediatrics - Pulmonary Medicine
Bio Dr. Tracy is a Clinical Assistant Professor in the Division of Pediatric Pulmonary. His clinical interests include care for children with bronchopulmonary dysplasia (BPD), chronic respiratory failure, mechanical ventilation, childhood interstitial lung disease, and cystic fibrosis. He serves as the director of the BPD Clinic, and co-director of the Cardiac and Respiratory care for Infants with BPD (CRIB) Program. He is the physician lead for the inpatient Pulmonary consult service at LPCH. Dr. Tracy is currently involved clinical and translational research projects in the area of BPD and cystic fibrosis. With regard to medical education, he was formerly a chief resident in pediatrics at LPCH, and currently serves as a faculty coach in the pediatric residency program.
-
Katherine Travis
Assistant Professor (Research) of Pediatrics (Developmental-Behavioral Pediatrics)
Bio Dr. Katherine Travis is an Assistant Professor in the Division of Developmental-Behavioral Pediatrics at Stanford University. Dr. Travis obtained her Ph.D. in Neuroscience from the University of California San Diego. Dr. Travis came to Stanford as a postdoctoral fellow to obtain training in clinical neuroscience and translational approaches to intervention. As part of her training, she was awarded a K99/R00 Pathway to Independence grant from the National Institutes of Health.
Her research uses human neuroimaging and behavioral measures to examine the neural bases of early language learning in infants and young children. The goal of her research is to develop therapies and interventions to help promote language learning outcomes in children at-risk for learning disabilities. Currently, she directs an NIH-funded clinical trial that will use diffusion MRI to assess whether there are changes in brain structure following a language intervention in the Neonatal Intensive Care Unit for preterm infants. -
Annie Trumbull
Life Science Research Professional, Pediatrics - Gastroenterology
Current Role at Stanford Life Science Research Professional
-
Yousef Turshani MD FAAP
Adjunct Clinical Assistant Professor, Pediatrics - General Pediatrics
Bio Yousef Turshani MD is Pediatric Medical Director at Fair Oaks Health Center in Redwood City, part of the County of San Mateo leadership team.
Dr Turshani is a leader in iMPACt: Mid-peninsula Pediatric Advocacy Coalition. https://med.stanford.edu/pedsadvocacy/engagement/impactcoalition.html
Born to Libyan immigrants in Louisville, KY, he developed his passion for teaching and global health as a medical student at the University of Chicago. His pediatric residency began with UCLA's "Community Health and Advocacy Training" and completed at UCSF in 2009 when he joined the UCSF faculty as a neonatal hospitalist at California Pacific Medical Center, directing the newborn nursery rotation for medical students. He spent the next part of his career as a global health clinician until returning to California in 2014 with his wife, a human rights attorney, to continue their social justice work domestically.
Professional Affiliations:
-UC-San Francisco: Associate Clinical Professor-VOL, Department of Pediatrics. Affiliate Faculty member at Institute for Global Health Sciences, HEAL Initiative Mentor
-American Board of Pediatrics: General Pediatrics Exam Committee Member
International experiences include
-Former Chair of Pediatrics at the only hospital on Saipan (Commonwealth of the Northern Mariana Islands)
-HIV consultant in Zimbabwe for "Doctors without Borders" collaborating with ICRC, UNICEF and partners to hand over a Pediatric HIV project to the Ministry of Health.
-Evaluating community health workers in Nicaragua
-Disaster relief work in Iceland and Peru
-Pediatric resident rotation in San Pedro Sula, Honduras -
Sriram Vaidyanathan
Postdoctoral Research Fellow, Stem Cell Transplantation
Bio I am a postdoctoral scholar working with Dr. Matthew Porteus. Gene therapy has been my primary research interest during my doctoral and postdoctoral training. As a doctoral student, I studied the intracellular transport of non-viral gene delivery vectors to optimize delivery. I joined the Porteus lab to further my interest in gene therapy by applying CRISPR/Cas9 based genome editing for monogenic diseases. As a postdoctoral scholar, I have been working on using CRISPR/Cas9 technology to develop an autologous gene corrected airway stem cell therapy to treat cystic fibrosis.
-
Tulio Valdez
Associate Professor of Otolaryngology (Pediatric) and, by courtesy, of Pediatrics at the Lucile Salter Packard Children's Hospital
Bio Dr. Tulio A Valdez is a surgeon scientist born and raised in Colombia with a subspecialty interest in Pediatric Otolaryngology. He attended medical school at Universidad Javeriana in Bogota Colombia before undertaking his residency in Otolaryngology, Head and Neck Surgery in Boston. He completed his Pediatric Otolaryngology Fellowship at Texas Children?s Hospital (2007), Houston and obtained his Master?s in Clinical and Translational Research at the University of Connecticut.
Clinically, Dr. Valdez has an interest in airway surgery and swallowing disorders. He has a special interest in the management of sinus disease in cystic fibrosis. Dr. Valdez has co-authored one textbook and numerous book chapters and scientific manuscripts. Dr. Valdez continues his clinical research in these areas, particularly with a focus on aerodigestive disorders.
Scientifically, Dr. Valdez has developed various imaging methods to diagnose otitis media and cholesteatoma a middle ear condition that can lead to hearing loss. He was part of the Laser Biomedical Research Center at Massachusetts Institute of Technology. His research includes novel imaging modalities to better diagnose ear infections one of the most common pediatric problems. His research has now expanded to include better intraoperative imaging modalities in pediatric patients to improve surgical outcomes without the need for radiation exposure.
Dr. Valdez believes in the multi-disciplinary collaborations to tackle medical problems and has co-invented various medical devices and surgical simulation models. -
Keith Van Haren, MD
Assistant Professor of Neurology and of Pediatrics at the Stanford University Medical Center
Current Research and Scholarly Interests Our research group is dedicated to innovating care for children with degenerative brain disorders. We are particularly focused on genetic and autoimmune disorders that cause damage to the myelin (the fatty insulation around the nerves) of the brain and spinal cord. X-linked adrenoleukodystrophy (genetic) and multiple sclerosis (autoimmune) are the prototypical examples of degenerative disorders of myelin and are the two disorders we study most intensively.
-
Krisa Van Meurs
Rosemarie Hess Professor in Neonatal and Developmental Medicine
Current Research and Scholarly Interests My research interests include persistent pulmonary hypertension of the newborn, hypoxic respiratory failure, inhaled nitric oxide therapy, ECMO, congenital diaphragmatic hernia, neonatal clinical trials, and the use of aEEG and NIRS to detect brain injury.
